![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 40, 30036-30045, October 6, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






¶
1
From the
Leonard and Madlyn Abramson Family Cancer Research Institute and ¶Howard Hughes Medical Institute, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania 19104 and the
Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health and Science University, Portland, Oregon 972001
Protein misfolding in the endoplasmic reticulum (ER) triggers a signaling pathway termed the unfolded protein response path-way (UPR). UPR signaling is transduced through the transmembrane ER effectors PKR-like ER kinase (PERK), inositol requiring kinase-1 (IRE-1), and activating transcription factor 6 (ATF6). PERK activation triggers phosphorylation of eIF2
leading to repression of protein synthesis, thereby relieving ER protein load and directly inhibiting cyclin D1 translation thereby contributing to cell cycle arrest. However, PERK-/- murine embryonic fibroblasts have an attenuated G1/S arrest that is not attributable to cyclin D1 loss, suggesting a cyclin D1-independent mechanism. Here we show that the UPR triggers p53 accumulation and activation. UPR induction promotes enhanced interaction between the ribosome proteins (rpL5, rpL11, and rpL23) and Hdm2 in a PERK-dependent manner. Interaction with ribosomal proteins results in inhibition of Hdm2-mediated ubiquitination and degradation of p53. Our data demonstrate that ribosomal subunit:Hdm2 association couples the unfolded protein response to p53-dependent cell cycle arrest.
Received for publication, May 16, 2006 , and in revised form, July 26, 2006.
* This work was supported by National Institutes of Health Grant P01 CA104838, a leukemia lymphoma scholar award, and the Abramson Family Cancer Research Institute (to J. A. D.), and by Grants CA093614 and CA095441 (to H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: The Leonard and Madlyn Abramson Family Cancer Research Institute, Dept. of Cancer Biology, 454 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104. Tel.: 215-746-6389; Fax: 215-746-5511; E-mail: adiehl{at}mail.med.upenn.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Aggarwal, M. D. Lessie, D. I. Lin, L. Pontano, A. B. Gladden, B. Nuskey, A. Goradia, M. A. Wasik, A. J.P. Klein-Szanto, A. K. Rustgi, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication Genes & Dev., November 15, 2007; 21(22): 2908 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baltzis, O. Pluquet, A. I. Papadakis, S. Kazemi, L.-K. Qu, and A. E. Koromilas The eIF2{alpha} Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53 J. Biol. Chem., October 26, 2007; 282(43): 31675 - 31687. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lai, T. Teodoro, and A. Volchuk Endoplasmic Reticulum Stress: Signaling the Unfolded Protein Response Physiology, June 1, 2007; 22(3): 193 - 201. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |